Thambisetty, M;
Howard, R;
(2024)
Conveying Risks of Harm in Alzheimer Disease by Amyloid Lowering.
JAMA: Journal of the American Medical Association
10.1001/jama.2024.7548.
Preview |
Text
Howard_Conveying risks of harm in Alzheimers by amyloid lowering_REV2_TRACKED.pdf Download (255kB) | Preview |
Abstract
This Viewpoint discusses how data gaps in published research impede clinicians’ ability to clearly discuss the risks and benefits of amyloid-lowering drugs for treating Alzheimer disease.
Type: | Article |
---|---|
Title: | Conveying Risks of Harm in Alzheimer Disease by Amyloid Lowering |
Location: | United States |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1001/jama.2024.7548 |
Publisher version: | http://dx.doi.org/10.1001/jama.2024.7548 |
Language: | English |
Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
Keywords: | Science & Technology, Life Sciences & Biomedicine, Medicine, General & Internal, General & Internal Medicine |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > Division of Psychiatry UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > Division of Psychiatry > Mental Health of Older People |
URI: | https://discovery.ucl.ac.uk/id/eprint/10193425 |
Downloads since deposit
0Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months
Archive Staff Only
![]() |
View Item |